The Use of Divalproex in the Treatment of Addictive Disorders
By Hugh Myrick, MD and Kathleen T. Brady, MD, PhD
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
Valproate Use in Neuropsychiatric Disorders in the Elderly
By Pierre N. Tariot, MD
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
Late-Life Anxiety Disorders
By Carl Salzman, MD
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
Panel Discussion